Across
- 4. Long-acting beta₂-agonist in Trelegy
- 5. Alternative inhaler: budesonide/formoterol
- 8. Inhaled corticosteroid component of Trelegy Ellipta
- 11. Two-time-daily dosing abbreviation
Down
- 1. Long-acting muscarinic antagonist in Trelegy
- 2. Condition requiring rinsing the mouth after inhaled corticosteroids
- 3. Contraindication involving increased eye pressure risk
- 6. Ellipta Triple-therapy inhaler used for COPD and asthma
- 7. Chronic lung condition Trelegy is primarily indicated for
- 9. Organ responsible for metabolizing all three components
- 10. Trelegy component class that reduces airway inflammation